CliffBio
small molecule

TAUVID

FLORTAUCIPIR F-18

Loss of exclusivityMay 2032latest FDA-listed patent expiry
CompanyAvid Radiopharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameTAUVID
Active ingredientFLORTAUCIPIR F-18
Strength50ML (8.1-51mCi/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMay 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
8932557May 2032substance

More from Avid Radiopharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TAUVID patent cliff — loss of exclusivity May 2032 | CliffBio